Patents by Inventor Tyler Cullender

Tyler Cullender has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Flagellum and anti-flagellum antibody levels in samples as a diagnostic biomarker and therapeutic target for metabolic syndrome
    Patent number: 9885089
    Abstract: High levels of bacterial flagella in a sample such as a gastrointestinal sample and/or low levels of anti-flagella antibodies serve as an indication for metabolic syndrome (such as insulin resistance, hypertension, elevated cholesterol, increased risk for blood clotting, and obesity) with highest levels of adiposity. An intervention that reduces the level and/or activity of flagella in the gastrointestinal tract can mitigate the severity of metabolic syndrome or in protecting against the development of metabolic syndrome.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: February 6, 2018
    Assignee: CORNELL UNIVERSITY
    Inventors: Ruth E. Ley, Tyler Cullender
  • FLAGELLUM AND ANTI-FLAGELLUM ANTIBODY LEVELS IN SAMPLES AS A DIAGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR METABOLIC SYNDROME
    Publication number: 20150050293
    Abstract: High levels of bacterial flagella in a sample such as a gastrointestinal sample and/or low levels of anti-flagella antibodies serve as an indication for metabolic syndrome (such as insulin resistance, hypertension, elevated cholesterol, increased risk for blood clotting, and obesity) with highest levels of adiposity. An intervention that reduces the level and/or activity of flagella in the gastrointestinal tract can mitigate the severity of metabolic syndrome or in protecting against the development of metabolic syndrome.
    Type: Application
    Filed: March 5, 2013
    Publication date: February 19, 2015
    Applicant: CORNELL UNIVERSITY
    Inventors: Ruth E. Ley, Tyler Cullender